MARKET PULSE-Sarepta, Leap, Intermune, Netflix, Smith & Wesson

Oct 3 (Reuters) - Some U.S. stocks on the move on Wednesday:

(For the Morning News Call newsletter click on ;

For The Day Ahead newsletter click on )


U.S. stocks edged higher on Wednesday after stronger-than-expected data in the services and private employment sectors, but lower oil and metals prices hurt energy and materials shares.

The Dow Jones industrial average gained 0.10 percent. The Standard & Poor's 500 Index added 0.18 percent. The Nasdaq Composite Index rose 0.31 percent.

** SAREPTA THERAPEUTICS INC , $40.19, up 168 pct (1100 ET)

The company said its experimental drug improved walking ability in boys with a rare muscle disorder.

** BIOLASE INC , $2.11, up 27 pct (1021 ET)

The company said health regulators in Europe and the United States approved its laser device for use in soft tissue surgery, teeth whitening, and pain therapy.

** OCWEN FINANCIAL CORP , $34.59, up 19.4 pct (1019 ET)

The loan servicer will buy Homeward Residential Holdings Inc from private equity firm WL Ross & Co LLC for about $750 million to strengthen its hold on the residential mortgage servicing market.

** BIOLINE RX LTD , $3.01, up 15.5 pct (1020 ET)

Aegis Capital initiated coverage of the Israeli biopharmaceutical company with a "buy" rating and a price target of $11 per share, saying the company was one of the most undervalued entities in the biotechnology sector.

** XYRATEX LTD , $7.38, down 15.2 pct (1038 ET)

The network and storage equipment maker's third-quarter results missed analysts estimates as demand in the enterprise sector fell. The company forecast a surprise loss for the current quarter.

Brean Murray cut its price target on the stock. ** METROPCS INC , $12.71, down 6.2 pct (1040 ET)

Deutsche Telekom and MetroPCS said they will merge their U.S. mobile operations to create a larger fourth-place player better able to compete with rivals.

** LEAP WIRELESS INTERNATIONAL INC , $6.50, down 14.2 pct

J.P. Morgan Securities downgraded the low-cost mobile services provider to "neutral" from "overweight," saying the stock has reached its fair value after the just announced Deutsche Telekom and MetroPCS merger.

** INTERMUNE INC , $9.66, up 9.2 pct (1037 ET)

The biotechnology company said Canadian health regulators approved its drug to treat idiopathic pulmonary fibrosis, a fatal lung disease.

** RIGEL PHARMACEUTICALS INC , $9.44, down 8.8 pct (1038 ET)

The clinical-stage drug development company announced a public offering of 13.7 million common shares priced at $9.50 each.

** HEARTLAND PAYMENT SYSTEMS INC , $30.13, down 8.1 pct (1020 ET)

Stifel Nicolaus cut the company's stock to 'sell' saying the company was at risk from falling prices in the small and midsized enterprises segment where start-ups like Square Inc are gaining traction.

** ANTARES PHARMA INC , $4.05, down 7.9 pct (1018 ET)

The company said its public offering of 12.5 million shares was priced at a discount.

** NETFLIX INC , $60.83 up 7.7 pct (1018 ET)

Citi Investment Research said Netflix's generally positive track record and reasonable valuation made the online streaming video company a "screaming" buy, despite significant risks.

** US AIRWAYS GROUP INC , $11.56, up 6.25 pct (1107 ET)

The air carrier said it expects its full-year total system capacity to be up 2 percent, compared with a year earlier, and domestic capacity to rise 2 percent. It also said it expects to end third quarter with about $2.75 billion in total cash and cash equivalents.

** STRATASYS INC , $60.09, up 6 pct (1034 ET)

Craig-Hallum Capital upgraded the three-dimensional printer maker's stock to "buy" from "hold," and raised its price target to $70 from $50, reported.

** FAMILY DOLLAR STORES INC , $69.29, up 4.8 pct (1035 ET)

The company reported a higher quarterly profit on Wednesday that met analysts' estimates, as increased sales of food and other basic goods brought shoppers into the stores and did not pressure margins as much as expected.

** SUPERIOR ENERGY SERVICES INC , $19.45, down 4.46 percent (1111 ET)

The oilfield services company estimated a weak third-quarter profit as operations in the U.S. Gulf of Mexico were hit by Hurricane Isaac.

Raymond James analysts cut the price target on the company's stock to $22.50 from $25.50.

** GENETIC TECHNOLOGIES LTD , $3.72, up 4.2 pct (1022 ET)

Phenogen Sciences, the U.S. unit of the Australia-based company, launched its lead cancer test BrevaGen in 49 states in the United States. The genetic test maker said it expects to sell the product, designed to help physicians assess breast cancer risk in patients, in New York next year.

** SMITH & WESSON HOLDING CORP , $10.44, down 4.1 pct (1045 ET)

** STURM RUGER & COMPANY INC , $47.47, down 2.4 pct (1046 ET)

Brokerage Benchmark Co analyst Mike Greene said the growth in adjusted Federal Bureau of Investigation background checks, which represent firearm sales, slowed to 14.7 percent in September, after growth of above 20 percent for the past four months.

** ARQULE INC , $2.26, up 3.6 pct (1042 ET)

The stock regained some value after plunging about 60 percent on Tuesday when the biotechnology company said it will discontinue a late-stage trial of a lung cancer drug it was co-developing with Japan's Daiichi Sankyo Co Ltd .

** MONSANTO CO , $88.01, down 2.8 pct (1039 ET)

The global agribusiness group posted a fourth-quarter loss, as expected, amid a seasonally sluggish sales period, and offered a conservative outlook for the new year.

** BEST BUY CO INC , $17.46, up 2.9 pct (1040 ET)

The company's founder Richard Schulze and at least four private equity firms have started examining the books of the world's largest consumer electronics chain, in early steps toward what could become a potential $11 billion buyout, according to people familiar with the matter.

** B&G FOODS INC , $30.40, down 2.4 pct (1041 ET)

The company, which sells Ortega Mexican food and Cream of Wheat hot cereals, said it priced its public offering of 3.6 million shares at $30.25 per share - a 3.5 percent discount. The proceeds from the offering would be used to pay down its debt and costs related to the acquisition of the New York Style and Old London brands.

** WALGREEN CO , Tuesday close $36.34, down 1.5 pct (1040 ET)

The largest U.S. drugstore chain reported a nearly 8 percent decline in September sales as calendar day shifts hurt pharmacy sales along with generic drug introductions.

** SOURCEFIRE INC , $47.04, down 1.9 pct (1042 ET)

The cyber-security software maker said on Tuesday that Chief Executive John Burris will step down, effective immediately, three months after he had taken medical leave of absence to undergo treatment for colon cancer.

(Complied by Aditi Shrivastava in Bangalore)

(, within U.S. +1 646 223 8780, outside U.S. +91 80 4135 5783, Reuters messaging: